http://www.aktiencheck.de aktiencheck.de aktiencheck.de Sat, 18 Apr 2026 16:33:53 +0200 2 http://www.aktiencheck.de/forum/VIRAGEN_Inc_AMEX_review-A0B8AG-t199712 http://www.aktiencheck.de/forum/VIRAGEN_Inc_AMEX_review-A0B8AG-t199712 Gibt es einen Grund, warum der Kurs die letzten Tag so ansteigt ? [<a href="http://www.aktiencheck.de/forum/VIRAGEN_Inc_AMEX_review-A0B8AG-t199712">mehr</a>] http://www.aktiencheck.de/forum/Newsforum_zu_Viragen-A0B8AG-t168399 http://www.aktiencheck.de/forum/Newsforum_zu_Viragen-A0B8AG-t168399 Multiferon - Phase II/III clinical trial conducted, Viragen Issues Progress Report PLANTATION, FLORIDA &#8211; August 19th, 2004 &#8211; Viragen, Inc. (AMEX: &#8220;VRA&#8221;) today issued a progress report updating the status of new growth strategies for its natural human alpha interferon drug, Multiferon&#8482;. Viragen previously reported promising preliminary data from a Phase II/III clinical trial conducted in Germany that evaluated the use of Multiferon for the treatment of malignant melanoma. &#8220;The final data collected from our melanoma study has been delivered to an independent Contract Research Organization for statistical determinations and we anticipate receiving the final results in the coming weeks,&#8221; stated Viragen&#8217;s President and CEO, Charles A. Rice. &#8220;If the evidence supports, we intend to submit a registration filing with the Swedish regulatory authorities for this new indication, which if approved, wou [<a href="http://www.aktiencheck.de/forum/Newsforum_zu_Viragen-A0B8AG-t168399">mehr</a>]